Risk Factors for a Severe Disease Course in Children With Sars-Cov-2 Infection Following Hematopoietic Cell Transplantation in the Pre-Omicron Period: A Prospective Multinational Infectious Disease Working Party From the European Society for Blood and Marrow Transplantation Group (Ebmt) and the Spanish Group of Hematopoietic Stem Cell Transplantation (Geth) Study Publisher Pubmed



Averbuch D¹ ; De La Camara R² ; Tridello G³ ; Knelange NS⁴ ; Bykova TA⁵ ; Ifversen M⁶ ; Dobsinska V^{7, 8} ; Ayas M⁹ ; Hamidieh AA¹⁰ ; Pichler H¹¹ ; Perezmartinez A¹² ; Cesaro S³ ; Sundin M¹³ ; Badell I¹⁴ Show All Authors
Source: Bone Marrow Transplantation Published:2023

Abstract

Risk factors for severe SARS-Cov-2 infection course are poorly described in children following hematopoietic cell transplantation (HCT). In this international study, we analyzed factors associated with a severe course (intensive care unit (ICU) admission and/or mortality) in post-HCT children. Eighty-nine children (58% male; median age 9 years (min-max 1–18)) who received an allogeneic (85; 96%) or an autologous (4; 4%) HCT were reported from 28 centers (18 countries). Median time from HCT to SARS-Cov-2 infection was 7 months (min-max 0–181). The most common clinical manifestations included fever (37; 42%) and cough (26; 29%); 37 (42%) were asymptomatic. Nine (10%) children following allo-HCT required ICU care. Seven children (8%) following allo-HCT, died at a median of 22 days after SARS-Cov-2 diagnosis. In a univariate analysis, the probability of a severe disease course was higher in allo-HCT children with chronic GVHD, non-malignant disease, immune suppressive treatment (specifically, mycophenolate), moderate immunodeficiency score, low Lansky score, fever, cough, coinfection, pulmonary radiological findings, and high C-reactive protein. In conclusion, SARS-Cov-2 infection in children following HCT was frequently asymptomatic. Despite this, 10% needed ICU admission and 8% died in our cohort. Certain HCT, underlying disease, and SARS-Cov-2 related factors were associated with a severe disease course. © 2023, The Author(s), under exclusive licence to Springer Nature Limited.